罗氏万赛维能医保吗？

(Valganciclovir Hydrochloride Tablets) is currently approved for the prevention of cytomegalovirus (CMV) disease after kidney, heart, and combined kidney and pancreas transplantation, and should be used within 100 days after transplantation. Previous studies have shown that although Vancevir can effectively protect patients from CMV infection or CMV disease during prophylactic treatment (100 days), some patients still develop CMV infection or CMV disease after stopping Vancevir. Currently, the drug has been approved for marketing in the country. Drug prices have always been a matter of great concern to patients, so is Roche Vancevir covered by medical insurance?

It is reported that Roche’s Vancevir is not currently reimbursable by medical insurance, but it is believed that with the joint efforts and promotion of all parties, the drug will be included in medical insurance as soon as possible to reduce a certain financial burden on patients’ treatment. The price of Vancevir before medical insurance is about $1.7, and the drug specification is 450mg*60 tablets/box. In order to reduce the financial burden, patients can give priority to purchasing drugs overseas. The Turkish version of Vancevi with the same specifications is only priced at around $3,000. Patients in need can obtain their specific drug purchase channels through Medical Companion Travel.

Roche Vancevir should be taken orally with food. For patients with active CMV retinitis, the recommended dose of Vancevir is 900 mg twice a day, and the induction treatment time is 21 days; during the maintenance treatment period, the recommended dose of Vancevir for patients with active or inactive CMV retinitis is 900 mg once a day. For kidney transplant patients, treatment with Vancevir should begin within 10 days after transplantation. The recommended usage is 900 mg once a day, and the treatment time should continue until 200 days after transplantation. For patients who have received solid organ transplants other than kidneys, treatment should begin within 10 days after transplantation. The recommended dosage is 900 mg once a day, and treatment should continue until 100 days after transplantation. Roche attaches great importance to scientific research. It has developed a variety of breakthrough new drugs that have not only achieved considerable economic benefits, but also promoted social benefits for human health.

Recommended hot articles: /newsDetail/90809.html